BiotechTube
Home/Keapstone Therapeutics/Dr Richard Mead
DR

Dr Richard Mead

Co-Founder, Board Member, Senior Lecturer at SITraN

Keapstone Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesParkinson's DiseaseAmyotrophic Lateral Sclerosis (ALS)

Keapstone Therapeutics Pipeline

DrugIndicationPhase
Nrf2 Activator ProgramParkinson's DiseasePre-clinical

Leadership Team at Keapstone Therapeutics

DP
Dame Professor Pamela Shaw
Co-Founder, Director of SITraN
RM
Ross McMaster
Company Secretary, Board Member, Financial Consultant
AR
Arthur Roach
Board Member, Director of Research at Parkinson's UK
View full Keapstone Therapeutics profile